Tomoe Shimazaki

Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma

Kazumasa Hiroishi, Junichi Eguchi, Toshiyuki Baba et al. · Journal of Gastroenterology · 2009 · 157 citations

Cancer Immunosurveillance, Medicine, Immunology +10

Fibroblast growth factor-2–mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma

Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka et al. · Carcinogenesis · 2017 · 99 citations · Full text

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

Masatsugu Ohara, Koji Ogawa, Goki Suda et al. · Hepatology Communications · 2018 · 85 citations · Full text

Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling

Taku Shigesawa, Osamu Maehara, Goki Suda et al. · Carcinogenesis · 2020 · 74 citations · Full text

Selective Fgfr Inhibitors, Stem Cell Biology, Cancer Biology +20

Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region

Akihiro Nakamura, Tomoe Shimazaki, Kazuhiro Kaneko et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2002 · 66 citations

Transcriptional Regulation, Promoter Region, Medicine +9